The present study, demonstrating that chymase inhibition significantly attenuated both cardiac hypertrophy and fibrosis, suggests that suppression of MMP-2 activation might contribute, at least in part, to the beneficial effects of chymase inhibition on cardiac remodeling. Here, CMA1 is linked to cardiac hypertrophy.